Vaccine for West Nile virus enters human clinical trials
7 July 2015 | By Victoria White
A new investigational vaccine designed to protect against West Nile Virus infection is being tested in a Phase 1 clinical trial...
List view / Grid view
News
Bavarian Nordic receives bulk order for Imvamune smallpox vaccine
7 July 2015 | By Victoria White
BARDA, a division of the US Department of Health & Human Services, has ordered a bulk supply of Bavarian Nordic’s Imvamune non-replicating smallpox vaccine...
Phase III data show significant overall survival benefit of afatinib compared to erlotinib in patients with SCC
6 July 2015 | By Victoria White
Results from the LUX-Lung 8 Trial demonstrate that afatinib resulted in superior progression-free survival and overall survival compared to erlotinib...
Patients with dementia not getting enough help from health and social care services, say GPs
6 July 2015 | By Victoria White
Over three quarters of UK GPs think their patients with dementia rely on family as they do not get enough help from health and social care services...
Allergan to acquire Oculeve dry eye disease development programmes
6 July 2015 | By Victoria White
Allergan is to acquire Oculeve. The acquisition will add novel, complementary dry eye development programmes to Allergan's portfolio...
World Zoonosis Day: Now is the time to take the bite out of rabies
6 July 2015 | By Victoria White
Despite being preventable thanks to vaccines, over 60,000 people die from rabies each year making it one of the world’s most deadly infectious diseases...
Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC
6 July 2015 | By Victoria White
Results from a study on the efficacy of cetuximab plus FOLFOX chemo as second-line treatment for patients with mCRC were presented at the ESMO 2015 congress...
ViiV Healthcare and Desano manufacturing agreement will bring competitive supply of dolutegravir to China
3 July 2015 | By Victoria White
ViiV Healthcare and Desano Pharmaceuticals have announced a strategic manufacturing agreement to enable production of dolutegravir in China...
New test could predict biologic drug failure in patients with arthritis
3 July 2015 | By Victoria White
A study has found that it may be possible to predict early which rheumatoid arthritis patients will fail to respond to the biologic drugs given to them...
EC approves Stelara for the treatment of plaque psoriasis in adolescent patients
3 July 2015 | By Victoria White
The EC has approved Janssen’s Stelara for the treatment of moderate-to-severe plaque psoriasis in adolescent patients from the age of 12 years and older...
FDA approves cystic fibrosis treatment Orkambi
3 July 2015 | By Victoria White
The FDA has approved Vertex’s Orkambi, the first medicine to treat the underlying cause of cystic fibrosis in people with two copies of the F508del mutation...
FSA accepts for review NDA for a once daily formulation of Xeljanz modified release tablets
3 July 2015 | By Victoria White
The FDA has accepted for review Pfizer’s new drug application (NDA) for Xeljanz (tofacitinib citrate) 11 mg once daily modified release tablets...
Studies confirm regorafenib benefit in pre-treated metastatic colorectal cancer
3 July 2015 | By Victoria White
The Phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC)...
Gene therapy offers hope for cystic fibrosis patients
3 July 2015 | By Victoria White
A therapy that replaces the faulty gene responsible for cystic fibrosis in patients' lungs has produced encouraging results in a major UK trial...
UK leads Europe in antimicrobial point-of-care diagnostics research
2 July 2015 | By Victoria White
The UK takes the lead position when it comes to patent filings for antimicrobial point-of-care diagnostics in Europe...
